Dublin, April 04, 2019 (GLOBE NEWSWIRE) -- The "Global Neurofeedback Systems Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.
The global neurofeedback systems market was valued at US$ 820.7 Mn in 2017, and is expected to reach US$ 1,565.6 Mn by 2026, expanding at a CAGR of 7.5% from 2018 to 2026.
Market Insights
A neurological disorder is the electrical or biochemical abnormality of the human nervous system. The specific causes range from congenital abnormalities, genetic, lifestyle disorders to brain injury. Neurofeedback systems have been recognized as the most effective alternative treatment option for brain abnormalities. It is highly effective in patients showing non-compliance and resistance to medical therapy.
In the present scenario frequency neurofeedback system is reigning the type segment for neurofeedback systems. It employs 2 to 4 surface electrodes and is popularly known as surface neurofeedback system. High degree of simplicity, ease of operation and popularity among neurologists drive the frequency neurofeedback systems market growth. Functional magnetic resonance imaging (fMRI) is the latest neurofeedback system which is successful in modulating brain activity in the deep subcortical brain region. It is used during epileptic surgical procedures by neurologists.
Currently, 50 million people throughout the globe are suffering from epilepsy making it the most common neurological disease worldwide as published by Global Disease Burden (GDB) in Lancet journal. In epilepsy the human brain continuously misfires signals, hence neurofeedback systems modulate the brain by inhibiting slow waves and promoting mid-range frequency waves eventually preventing seizures. ADHD has been popular in the last decade owing to the severe adverse effects associated with its long term medication such as insomnia, anxiety, and loss of appetite. Neurofeedback systems have been successful in treating ADHD by decreasing brain activity in the theta band region and promoting activity in the beta band region.
North America currently represents a share of 60% and is the largest regional market in global neurofeedback systems market. The rising prevalence of neurological disease and the existence of advanced healthcare infrastructure drive the neurofeedback systems market growth in North America region. Europe with a share of 20% is the second largest market owing to the increasing number of patients suffering from insomnia and anxiety. Asia Pacific currently holds 8% market share and is on the path to register impressive growth in the near future on account of developing healthcare infrastructure and rampant growth in neurological disease diagnosis and treatment.
Medical device manufacturers producing EEG equipment for neurofeedback systems are BrainMaster Technologies, Inc., BEE Medic GmbH, Mind Media B.V., Mitsar Co., Ltd., Myndlift, Neurobit Systems, NeuroCare Group GmbH, Stens Corporation, Thought Technology Ltd. and Wearable Sensing.
Key Market Movements
Key Topics Covered:
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Scope
1.3. Research Methodology
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Neurofeedback Systems Market Portraiture
2.2. Global Neurofeedback Systems Market, by Type, 2017 (US$ Mn)
2.3. Global Neurofeedback Systems Market, by Application, 2017 (US$ Mn)
2.4. Global Neurofeedback Systems Market, by Geography, 2017 (US$ Mn)
Chapter 3. Neurofeedback Systems Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Neurofeedback Systems Market, by Key Players, 2017
Chapter 4. Global Neurofeedback Systems Market, by Type
4.1. Overview
4.2. Frequency Neurofeedback System (FNS)
4.3. Low Energy Neurofeedback System (LENS)
4.4. Slow Cortical Potential Neurofeedback System (SCP-NF)
4.5. Hemoencephalographic Neurofeedback System (HEG)
4.6. Low Resolution Electromagnetic Tomography (LORE-TA)
4.7. Functional Magnetic Resonance Imaging (fMRI)
Chapter 5. Global Neurofeedback Systems Market, by Application
5.1. Overview
5.2. Attention Deficit Hyperactivity Disorder (ADHD)
5.3. Epilepsy
5.4. Anxiety
5.5. Insomnia
5.6. Migraine
5.7. Drug Addiction
5.8. Others
Chapter 6. Global Neurofeedback Systems Market, by Geography
Chapter 7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/fz7dh3
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Neurology Devices